Amdocs Limited Reports Third Quarter Fiscal 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Outlook Therapeutics (OTLK) halted, news pending
- Nasdaq lags on angst over AI spending ahead of earnings reports
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
Amdocs (DOX) Reports In-Line Q3 EPS
July 31, 2018 4:04 PM EDTAmdocs (NASDAQ: DOX) reported Q3 EPS of $1.03, in-line with the analyst estimate of $1.03. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.01 billion.
GUIDANCE:
Amdocs sees Q4 2018 EPS of $0.95-$1.01, versus the consensus of $1.02. Amdocs sees Q4... More
